List of Oncology Medication For

Chronic Disease

Specialty medications are used to treat patients with complex and/or rare diseases; have special dosage, storage, handling, and administration requirements; and require high touch patient care and monitoring services (eg, transplant, oncology, MS, hepatitis).

Lifyorli (relacorilant) capsules

Ovarian, Chronic Disease

Food and Drug Administration approved relacorilant (Lifyorli, Corcept Therapeutics Inc.), a glucocorticoid receptor antagonist, in combination with nab-paclitaxel for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic treatment regimens, at least one of which included bevacizumab. Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.

Brand Name:	Lifyorli
Generic Name:	relacorilant capsules
Strength:	Capsules: 100 mg / 25 mg
Manufacturer:	Corcept Therapeutics Incorporated
Approved By:	EMA, USFDA

Source Details: Patient Information.

Get access Lifyorli for ovarian cancer Treatment through Named-Patient Import in India

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to Lifyorli (relacorilant) for personal use. For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.

Lixisenatide Injection

Diabetes

Lixisenatide Prefilled Solution for Injection

Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Facts about Lixisenatide Injection

Approval Date: July 27, 2016
Proprietary Name: Lyxumia Lixisenatide Prefilled Solution for Injection
Active Ingredient(s): Lixisenatide Prefilled Solution for Injection
FDA-approved use: adults with type 2 diabetes mellitus
Dosage Form: solution for injection

Lyxumia 10 micrograms solution for injection
Lyxumia 20 micrograms solution for injection

Medicine Approved By: Food and Drug Administration (FDA), EMA
Manufacturer: sanofi-aventis

Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Lixisenatide Injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

LYNPARZA (olaparib) tablets

Breast Cancer, Ovarian, Pancreatic, Prostate

LYNPARZA (olaparib) tablets, for oral use Initial U.S. Approval: 2014

It targets specific enzymes within cancer cells and stops the cancer cell from growing. This medicine is used to treat certain kinds of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.

Brand Name:	LYNPARZA
Generic Name:	olaparib
Strength:	• Tablets: 150 mg, 100 mg
Manufacturer:	AstraZeneca
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “LYNPARZA (olaparib) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for LYNPARZA (olaparib) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Mavenclad (cladribine)

Neuro, Multiple Myeloma, Multiple Sclerosis

Mavenclad (cladribine)

Mavenclad (cladribine) is a brand-name oral tablet that’s prescribed for relapsing-remitting multiple sclerosis (MS) and active secondary progressive MS. This article covers topics such as side effects, dosage, and how Mavenclad works. Mavenclad belongs to a drug class called purine antimetabolites.

Brand Name:	Mavenclad
Generic Name:	cladribine
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Mavenclad (cladribine)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Mavenclad (cladribine) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Mayzent (Siponimod)

Multiple Sclerosis

Mayzent (Siponimod)

Mayzent helps to slow down the effects of multiple sclerosis (MS) such as worsening disability and decline in thinking. It may also slow down the nerve damage caused by MS and increase your time without relapse. Mayzent is used for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS).

Brand Name:	Mayzent
Generic Name:	Siponimod
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Mayzent (Siponimod)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Mayzent (Siponimod) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Mitotane Tablets

Kidney

mitotane tablets
for oral use Initial U.S. Approval: 1970

mitotane is an adrenal cytotoxic agent indicated for the treatment of inoperable, functional or nonfunctional, adrenal cortical carcinoma.

Facts about Mitotane tablets

Approval Date: 1970
Proprietary Name: On Request
Active Ingredient(s): Mitotane tablets
Dosage Forms And Strengths: Tablets: 500 mg, scored
Manufacturer: Bristol-Myers Squibb Company
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Mitotane tablets” based on the information you provide.

MOUNJARO (tirzepatide) Injection

Diabetes

MOUNJARO (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022

Mounjaro is an injectable medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if Mounjaro can be used in people who have had inflammation of the pancreas (pancreatitis). Mounjaro is not for use in people with type 1 diabetes.

Brand Name:	MOUNJARO
Generic Name:	tirzepatide
Strength:	Injection: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL in single-dose pen
Manufacturer:	Eli Lilly and Company
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “MOUNJARO (tirzepatide) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for MOUNJARO (tirzepatide) Injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

MYOBLOC (rimabotulinumtoxinB) injection

Cervical

MYOBLOC (rimabotulinumtoxinB) injection, for intramuscular or intraglandular use Initial U.S. Approval: 2000

MYOBLOC is a prescription medicine used in adults that is injected into: muscles and used to treat the abnormal head position and neck pain that happens with cervical dystonia (CD). glands that make saliva and is used to treat long-lasting (chronic) drooling (sialorrhea).

Brand Name:	MYOBLOC
Generic Name:	rimabotulinumtoxinB
Strength:	Injection: 2,500 Units/0.5 mL; 5,000 Units/mL; or 10,000 Units/2 mL (5,000 Units/mL) in a single-dose vial
Manufacturer:	Solstice Neurosciences
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “MYOBLOC (rimabotulinumtoxinB) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for MYOBLOC (rimabotulinumtoxinB) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Ocrevus (ocrelizumab)

Multiple Sclerosis, Neuro

Ocrevus (ocrelizumab)

OCREVUS is a prescription medicine used to treat: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Primary progressive MS, in adults.

Brand Name:	Ocrevus
Generic Name:	ocrelizumab
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Ocrevus (ocrelizumab)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Ocrevus (ocrelizumab) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection

Kidney, Chronic Disease, Colon, Esophageal, Gastrointestinal, Head And Neck, Lung Cancer, Solid Tumors, Urothelial Carcinoma

Brand Name: Opdivo Qvantig. Generic Name: (nivolumab and hyaluronidase-nvhy). It is used to treat Renal Cell Carcinoma (RCC), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN), Urothelial Carcinoma (UC), Colorectal Cancer, Hepatocellular Carcinoma (HCC), Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma..

OPDIVO QVANTIG is a combination of nivolumab, a programmed death receptor-1 (PD-1)-blocking antibody, and hyaluronidase, an endoglycosidase, indicated for the treatment of Renal Cell Carcinoma (RCC), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN), Urothelial Carcinoma (UC), Colorectal Cancer, Hepatocellular Carcinoma (HCC), Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma.

Brand Name:	Opdivo Qvantig
Generic Name:	nivolumab and hyaluronidase-nvhy
Strength:	• Injection: 600 mg nivolumab and 10,000 units hyaluronidase per 5 mL (120 mg/2,000 units per mL) in a single-dose vial.
Manufacturer:	Bristol-Myers Squibb
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Chronic Disease

Lifyorli (relacorilant) capsules

Get access Lifyorli for ovarian cancer Treatment through Named-Patient Import in India

Lixisenatide Injection

Lixisenatide Prefilled Solution for Injection

Facts about Lixisenatide Injection

Access the best support services globally

LYNPARZA (olaparib) tablets

LYNPARZA (olaparib) tablets, for oral use Initial U.S. Approval: 2014

Mavenclad (cladribine)

Mavenclad (cladribine)

Mayzent (Siponimod)

Mayzent (Siponimod)

Mitotane Tablets

mitotane tablets
for oral use Initial U.S. Approval: 1970

Facts about Mitotane tablets

Access the best support services globally

MOUNJARO (tirzepatide) Injection

MOUNJARO (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022

MYOBLOC (rimabotulinumtoxinB) injection

MYOBLOC (rimabotulinumtoxinB) injection, for intramuscular or intraglandular use Initial U.S. Approval: 2000

Ocrevus (ocrelizumab)

Ocrevus (ocrelizumab)

Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

Company

Drugs Approved for

Gastroenterology

Hematology

Drugs Approved For

Chronic Disease

Get access Lifyorli for ovarian cancer Treatment through Named-Patient Import in India

Lixisenatide Prefilled Solution for Injection

Facts about Lixisenatide Injection

Access the best support services globally

LYNPARZA (olaparib) tablets, for oral use Initial U.S. Approval: 2014

Mavenclad (cladribine)

Mayzent (Siponimod)

mitotane tablets for oral use Initial U.S. Approval: 1970

Facts about Mitotane tablets

Access the best support services globally

MOUNJARO (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022

MYOBLOC (rimabotulinumtoxinB) injection, for intramuscular or intraglandular use Initial U.S. Approval: 2000

Ocrevus (ocrelizumab)

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

mitotane tablets
for oral use Initial U.S. Approval: 1970